Financial Architects, Inc Spectrum Pharmaceuticals Inc Transaction History

Financial Architects, Inc

  • $657 Million
  • Q2 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 03, 2018
SELL
$14.31 - $21.75 $5,724 - $8,700
-400 Closed
0 $0
Q1 2018

Apr 23, 2018
BUY
$16.09 - $23.07 $1,609 - $2,307
100 Added 33.33%
400 $6,000
Q4 2017

Feb 12, 2018
BUY
$13.36 - $20.73 $4,008 - $6,219
300
300 $6,000

Others Institutions Holding SPPI

# of Institutions
1
Shares Held
115K
Call Options Held
0
Put Options Held
0
View Full List

About SPECTRUM PHARMACEUTICALS INC

SPPI Quotes by TradingView
  • Ticker SPPI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,164,000
  • Description
  • Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...
More about SPPI
Track This Portfolio

Track Financial Architects, Inc Portfolio

Follow Financial Architects, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Architects, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Financial Architects, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email